Related Experiment Video
Updated: Nov 26, 2025

Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
Published on: June 15, 2019
Hyaluronic acid in viscous malignant mesothelioma pleural effusion
Hui Min Cheah1,2, Deirdre Fitzgerald1,2,3, Amber Louw4,5
1Pleural Medicine Unit Center for Respiratory Health, University of Western Australia Perth WA Australia.
Abstract:
Malignant pleural effusion (MPE) is common with mesothelioma. We report two cases of extraordinarily viscous MPEs associated with mesothelioma. The viscosity prohibited spontaneous gravity-dependent drainage via indwelling pleural catheters. Our ex vivo experiments found very high hyaluronic acid (HA) content within the fluid. Treatment of the fluid with hyaluronidase, but not with deoxyribonucleases, significantly reduced fluid viscosity. The results provide proof that HA can contribute to high viscosity of pleural fluid in mesothelioma. Research into strategies of counteracting HA properties in the management of MPEs may provide further insight.
Insights
Malignant pleural effusions (MPEs) in mesothelioma can be extremely viscous due to high hyaluronic acid (HA) content. This viscosity hinders drainage, but hyaluronidase treatment shows promise in reducing MPE viscosity.
Area of Science:
- Oncology
- Pulmonology
- Biochemistry
Background:
- Malignant pleural effusion (MPE) is a frequent complication of mesothelioma.
- Viscous MPEs pose significant management challenges, impeding effective drainage.
Observation:
- Two cases of mesothelioma with unusually viscous MPEs were observed.
- The high viscosity prevented spontaneous drainage using indwelling pleural catheters.
Findings:
- Ex vivo analysis revealed exceptionally high concentrations of hyaluronic acid (HA) in the effusions.
- Treatment with hyaluronidase, an enzyme that degrades HA, significantly reduced fluid viscosity.
- Deoxyribonuclease treatment did not affect fluid viscosity, indicating HA's specific role.
Implications:
- Hyaluronic acid is a key contributor to the high viscosity of MPEs in mesothelioma.
- Targeting HA degradation may offer novel therapeutic strategies for managing viscous MPEs.
- Further research into counteracting HA properties could improve MPE management and patient outcomes.
Related Concept Videos
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Glycosaminoglycans
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
Mesenchymal Stem Cells
Lysosomal Hydrolases

